Literature DB >> 7677958

Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites.

J A Simpson1, J C Chow, J Baker, N Avdalovic, S Yuan, D Au, M S Co, M Vasquez, W J Britt, K L Coelingh.   

Abstract

Seven neutralizing murine monoclonal antibodies specific for the glycoprotein H of human cytomegalovirus were produced and used to construct a topological map of two nonoverlapping antigenic sites that are bridged by a third antigenic site. Neutralization assays with 15 laboratory or clinical human cytomegalovirus strains indicated that the monoclonal antibodies recognize three antigenically variable and three conserved epitopes within the three antigenic sites. The variable-domain genes encoding monoclonal antibodies representing each of the three antigenic sites were cloned and sequenced, and molecular models of their binding sites were generated. Conformational differences in the antibody-binding sites suggested a structural basis for experimentally observed differences in gH epitope recognition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7677958      PMCID: PMC237386     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  NMR-derived model for a peptide-antibody complex.

Authors:  B Zilber; T Scherf; M Levitt; J Anglister
Journal:  Biochemistry       Date:  1990-10-30       Impact factor: 3.162

2.  Probing antibody diversity by 2D NMR: comparison of amino acid sequences, predicted structures, and observed antibody-antigen interactions in complexes of two antipeptide antibodies.

Authors:  R Levy; O Assulin; T Scherf; M Levitt; J Anglister
Journal:  Biochemistry       Date:  1989-09-05       Impact factor: 3.162

3.  Complement-independent neutralising monoclonal antibody with differential reactivity for strains of human cytomegalovirus.

Authors:  C Baboonian; K Blake; J C Booth; C N Wiblin
Journal:  J Med Virol       Date:  1989-10       Impact factor: 2.327

4.  Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex.

Authors:  E A Padlan; E W Silverton; S Sheriff; G H Cohen; S J Smith-Gill; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol.

Authors:  J N Herron; X M He; M L Mason; E W Voss; A B Edmundson
Journal:  Proteins       Date:  1989

6.  Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.

Authors:  K L van Wyke Coelingh; C C Winter; E L Tierney; S L Hall; W T London; H W Kim; R M Chanock; B R Murphy
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

7.  Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response.

Authors:  W J Britt; L Vugler; E J Butfiloski; E B Stephens
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus.

Authors:  N Kniess; M Mach; J Fay; W J Britt
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans.

Authors:  L Rasmussen; C Matkin; R Spaete; C Pachl; T C Merigan
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

10.  The outcome of congenital cytomegalovirus infection in relation to maternal antibody status.

Authors:  K B Fowler; S Stagno; R F Pass; W J Britt; T J Boll; C A Alford
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

View more
  24 in total

1.  Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity.

Authors:  William J Britt
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

2.  Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly.

Authors:  V Sanchez; K D Greis; E Sztul; W J Britt
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.

Authors:  Nina Reuter; Barbara Kropff; Julia Karin Schneiderbanger; Mira Alt; Adalbert Krawczyk; Christian Sinzger; Thomas H Winkler; William J Britt; Michael Mach; Marco Thomas
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

Review 4.  Synthetic DNA approach to cytomegalovirus vaccine/immune therapy.

Authors:  Stephan J Wu; Daniel O Villarreal; Devon J Shedlock; David B Weiner
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  Importance of Highly Conserved Peptide Sites of Human Cytomegalovirus gO for Formation of the gH/gL/gO Complex.

Authors:  Cora Stegmann; Mohamed E A Abdellatif; Kerstin Laib Sampaio; Paul Walther; Christian Sinzger
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

6.  Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Authors:  Thomas J Gardner; Cynthia Bolovan-Fritts; Melissa W Teng; Veronika Redmann; Thomas A Kraus; Rhoda Sperling; Thomas Moran; William Britt; Leor S Weinberger; Domenico Tortorella
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

7.  Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans.

Authors:  Adam L Vanarsdall; Brent J Ryckman; Marie C Chase; David C Johnson
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion.

Authors:  Matthew Lopper; Teresa Compton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope.

Authors:  Pilailuk Akkapaiboon; Yasuko Mori; Tomohiko Sadaoka; Sayoko Yonemoto; Koichi Yamanishi
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.

Authors:  Devon J Shedlock; Kendra T Talbott; Stephan J Wu; Christine M Wilson; Karuppiah Muthumani; Jean D Boyer; Niranjan Y Sardesai; Sita Awasthi; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.